196 related articles for article (PubMed ID: 8374529)
1. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Nomura T
Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
[TBL] [Abstract][Full Text] [Related]
2. Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Futaki M; Dan K; Nomura T
Intern Med; 1994 Apr; 33(4):189-92. PubMed ID: 7520786
[TBL] [Abstract][Full Text] [Related]
3. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
[TBL] [Abstract][Full Text] [Related]
4. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
Mills KI; Sproul AM; Leibowitz D; Burnett AK
Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the site of breakpoints within the bcr gene and thrombopoiesis of Philadelphia-positive chronic myelocytic leukemia.
Inokuchi K; Futaki M; Yamada T; Tanabe Y; Dan K; Shinohara T; Kuriya S; Nomura T
Leuk Res; 1991; 15(11):1067-73. PubMed ID: 1961010
[TBL] [Abstract][Full Text] [Related]
6. Molecular studies of chronic myelogenous leukemia using the polymerase chain reaction.
Nakamura K; Miyashita T; Ozaki M; Iwaya M; Nakazawa S; Okamura J; Kamada N; Tanaka K; Kobayashi N; Mizutani S
Cancer; 1991 Dec; 68(11):2426-30. PubMed ID: 1933779
[TBL] [Abstract][Full Text] [Related]
7. Possible correlation between fusion pattern of BCR/ABL mRNA and clinical response to alpha-interferon in chronic myelogenous leukemia.
Inoue T; Tojo A; Tsuchimoto D; Okamoto S; Ogura H; Tani K; Ozawa K; Shibuya M; Asano S
Leukemia; 1992 Sep; 6(9):948-51. PubMed ID: 1518306
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.
Iwata S; Mizutani S; Nakazawa S; Yata J
Leukemia; 1994 Oct; 8(10):1696-702. PubMed ID: 7934165
[TBL] [Abstract][Full Text] [Related]
9. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
Furukawa Y; Ju SL; Cho HL; Tatsumi N
Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
[TBL] [Abstract][Full Text] [Related]
10. BCR-ABL rearrangements in children with Philadelphia chromosome-positive chronic myelogenous leukemia.
Aurer I; Butturini A; Gale RP
Blood; 1991 Nov; 78(9):2407-10. PubMed ID: 1932752
[TBL] [Abstract][Full Text] [Related]
11. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
[TBL] [Abstract][Full Text] [Related]
12. Predicting relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation by bcr-abl mRNA and DNA fingerprinting.
Okamoto R; Harano H; Matsuzaki M; Motomura S; Maruta A; Kodama F; Mohri H; Okubo T
Am J Clin Pathol; 1995 Nov; 104(5):510-6. PubMed ID: 7572810
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; FĂ©liz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
14. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
[TBL] [Abstract][Full Text] [Related]
15. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
[TBL] [Abstract][Full Text] [Related]
16. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
[TBL] [Abstract][Full Text] [Related]
18. The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.
Perego RA; Costantini M; Cornacchini G; Gargantini L; Bianchi C; Pungolino E; Rovida E; Morra E
Eur J Cancer; 2000 Jul; 36(11):1395-401. PubMed ID: 10899653
[TBL] [Abstract][Full Text] [Related]
19. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.
Hochhaus A; Reiter A; Skladny H; Melo JV; Sick C; Berger U; Guo JQ; Arlinghaus RB; Hehlmann R; Goldman JM; Cross NC
Blood; 1996 Sep; 88(6):2236-40. PubMed ID: 8822944
[TBL] [Abstract][Full Text] [Related]
20. Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.
Wells SJ; Phillips CN; Winton EF; Farhi DC
Am J Clin Pathol; 1996 Jun; 105(6):756-60. PubMed ID: 8659451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]